Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 12 Sponsors

May 29, 2026 · Senate

PASSED SENATE

May 29, 2026 · Senate

DELIVERED TO ASSEMBLY

May 29, 2026 · Assembly

REFERRED TO HEALTH

May 14, 2026 · Senate

ADVANCED TO THIRD READING

May 13, 2026 · Senate

2ND REPORT CAL.

May 12, 2026 · Senate

1ST REPORT CAL.1095

May 5, 2026 · Senate

AMEND AND RECOMMIT TO HEALTH

May 5, 2026 · Senate

PRINT NUMBER 6758B

Jan 16, 2026 · Senate

AMEND AND RECOMMIT TO HEALTH

Jan 16, 2026 · Senate

PRINT NUMBER 6758A

Jan 7, 2026 · Senate

REFERRED TO HEALTH

Mar 24, 2025 · Senate

REFERRED TO HEALTH

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +4 66/100 from the pace of recorded action
Time since last action -19 137 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.